Drugs Made In America Acquisition II Corp. (DMII) reporting calendar
Drugs Made In America Acquisition II Corp. files periodic reports with the SEC as DMII on Nasdaq. Atlas tracks 3 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 14 May 2026
- Reports on record
- 3
Open DMII market profile
Latest filing on SEC EDGAR ↗
Blank Checks reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 14 May 2026 | 44 days | 0001213900-26-056651 |
| 10-K | 31 Dec 2025 | 15 Apr 2026 | 105 days | 0001213900-26-044055 |
| 10-Q | 30 Sep 2025 | 18 Nov 2025 | 49 days | 0001213900-25-112095 |
Source: SEC EDGAR company submissions for CIK 0002040475. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.